ArticleOncotarget2017

Expression of embryonal stem cell transcription factors in breast cancer: Oct4 as an indicator for poor clinical outcome and tamoxifen resistance.

Jae Moon Gwak et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.